Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Improved FDA Forensics Uncover More Manufacturing Data Integrity Issues

This article was originally published in PharmAsia News

Executive Summary

The US FDA learned how to find hidden information during its investigation of Ranbaxy, with techniques including improved forensic examinations of computers, and mock inspections are being held at some Indian and Chinese sites ahead of FDA visits.

Advertisement

Related Content

House Demands More Info On FDA Overseas Operations
Ranbaxy’s $500 Million Settlement Includes Criminal Penalties

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC089482

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel